GOLDMAN SACHS GROUP INC - KITE PHARMA INC ownership

KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109. A total of 161 filers reported holding KITE PHARMA INC in Q3 2015. The put-call ratio across all filers is 0.60 and the average weighting 0.5%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of KITE PHARMA INC
ValueSharesWeighting
Q3 2017$151,378,000
+224.8%
841,880
+87.3%
0.04%
+208.3%
Q2 2017$46,608,000
+133.6%
449,580
+76.8%
0.01%
+100.0%
Q1 2017$19,956,000
+299.6%
254,244
+128.3%
0.01%
+500.0%
Q4 2016$4,994,000
-83.0%
111,386
-78.8%
0.00%
-88.9%
Q3 2016$29,325,000
+661.1%
524,968
+581.2%
0.01%
+800.0%
Q2 2016$3,853,000
-48.9%
77,062
-53.1%
0.00%
-66.7%
Q1 2016$7,536,000
-12.2%
164,183
+17.9%
0.00%0.0%
Q4 2015$8,581,000
-4.1%
139,263
-13.3%
0.00%0.0%
Q3 2015$8,947,000
+23.1%
160,683
+34.8%
0.00%0.0%
Q2 2015$7,269,000
+191.5%
119,226
+175.8%
0.00%
+200.0%
Q1 2015$2,494,00043,2360.00%
Other shareholders

There were no reported owners of KITE PHARMA INC in Q3 2015.

NameSharesValueWeighting ↓
View complete list of KITE PHARMA INC shareholders